Zobrazeno 1 - 10
of 640
pro vyhledávání: '"Maria R. Baer"'
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 491-494 (2023)
Externí odkaz:
https://doaj.org/article/1fc6a9ecfbfe4ecbac5f114f19ee91e8
Autor:
Bijal Shah, Ryan D. Cassaday, Jae H. Park, Roche Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Kristen M. O’dwyer, Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick Stiff, Lang Zhou, Tsveta Hadjivassileva, Rita Damico Khalid, Armin Ghobadi
Publikováno v:
HemaSphere, Vol 7, p e54499e3 (2023)
Externí odkaz:
https://doaj.org/article/7aed547152154c0faf9b4f2f5e348358
Autor:
Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-11 (2022)
Abstract Background Brexucabtagene autoleucel (KTE-X19) is an autologous anti-CD19 CAR T-cell therapy approved in the USA to treat adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL) based on ZUMA-3 study r
Externí odkaz:
https://doaj.org/article/c6f5581c75904c159d9b64a730068459
Publikováno v:
Genes, Vol 14, Iss 2, p 396 (2023)
Acute myeloid leukemia (AML) represents a heterogeneous disease entity that is continuously moving to a more genetically defined classification. The classification of AML with recurrent chromosomal translocations, including those involving core bindi
Externí odkaz:
https://doaj.org/article/ce63f0d39de2448d817464f7893a74bc
Autor:
Sarah M. Kashanian, Andrew Y. Li, Moaath Mustafa Ali, Mark E. Sutherland, Vu H. Duong, Bryan C. Hambley, Kyle Zacholski, Firas El Chaer, Noa G. Holtzman, Mohammad Imran, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Amy E. Dezern, Ivana Gojo, Kelly J. Norsworthy, Mark J. Levis, B. Douglas Smith, Maria R. Baer, Gabriel Ghiaur, Ashkan Emadi
Publikováno v:
eJHaem, Vol 2, Iss 1, Pp 33-39 (2021)
Abstract Introduction Obesity has become increasingly prevalent worldwide and is a risk factor for many malignancies. We studied the correlation between body mass index (BMI) and the incidence of acute promyelocytic leukemia (APL), non‐APL acute my
Externí odkaz:
https://doaj.org/article/cd21add081aa4af793dcc62f9befc578
Autor:
Elizabeth M. Corley, Moaath K. Mustafa Ali, Hanan Alharthy, Kathryn A. F. Kline, Danielle Sewell, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Ashkan Emadi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) is the common type of acute leukemia in adults. Definitive prognostic significance of variants of unknown significance lacks for many commonly mutated genes, including the isocitrate dehydrogenase 1 (IDH1) synonymous sing
Externí odkaz:
https://doaj.org/article/9ef9917eeaff4198b6ee6ac95bdbd640
Autor:
Moaath K. Mustafa Ali, Elizabeth M. Corley, Hanan Alharthy, Kathryn A. F. Kline, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Ashkan Emadi, Maria R. Baer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
There is a deficiency of real-world data on the impact of combining venetoclax (VEN) with hypomethylating agents (HMAs) in newly diagnosed acute myeloid leukemia (AML) patients. We conducted a single-center, propensity-adjusted retrospective cohort s
Externí odkaz:
https://doaj.org/article/a8829a8dd74a40fc9b48d7be3211c6d6
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 545-546 (2022)
Externí odkaz:
https://doaj.org/article/cbbe6551c0e94b5aba4ed0a5aa88e2fd
Autor:
Michael E. Kallen, Rima Koka, Zeba N. Singh, Yi Ning, Mehmet H. Kocoglu, Ashraf Z. Badros, Sandrine Niyongere, Vu H. Duong, Ashkan Emadi, Maria R. Baer
Publikováno v:
Leukemia Research Reports, Vol 18, Iss , Pp 100358- (2022)
New therapies for multiple myeloma have improved outcomes, but are associated with therapy-related hematologic malignancies. We report eight patients with therapy-related B-lymphoblastic leukemias (t-B-ALL) in the setting of therapy for multiple myel
Externí odkaz:
https://doaj.org/article/33542464236147448d22605a7dccfcab
Autor:
Anna J. Dellomo, Rachel Abbotts, Christian L. Eberly, Mariusz Karbowski, Maria R. Baer, Tami J. Kingsbury, Feyruz V. Rassool
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101283- (2022)
Signal transducer and activator of transcription 5 (STAT5) signaling plays a pathogenic role in both hematologic malignancies and solid tumors. In acute myeloid leukemia (AML), internal tandem duplications of fms-like tyrosine kinase 3 (FLT3-ITD) con
Externí odkaz:
https://doaj.org/article/1a37956d049b40a797eb0d03b6d03d1b